Insmed Inc. buy Guggenheim
Start price
27.02.24
/
50%
€26.80
Target price
27.02.25
€49.73
Performance (%)
155.60%
Price
29.08.24
€68.50
Summary
This prediction is currently active. The BUY prediction by Guggenheim for Insmed Inc. has seen massive gains of 155.60%. This prediction currently runs until 27.02.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Insmed Inc. | -3.521% | -3.521% |
iShares Core DAX® | 1.560% | 4.721% |
iShares Nasdaq 100 | 0.517% | 1.171% |
iShares Nikkei 225® | 1.730% | 6.073% |
iShares S&P 500 | 1.482% | 1.218% |
Comments by Guggenheim for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Guggenheim from $52.00 to $54.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat